Cryoport, Inc. officer Mark Sawicki filed a Form 144 notice on November 10, 2026, proposing the sale of 10,000 shares of Cryoport common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.
Key Highlights
- Proposed seller: Mark Sawicki, an officer of Cryoport, Inc., filed the notice of proposed sale.
- Shares proposed for sale: 10,000 shares of Cryoport common stock, with an aggregate market value of $199,261.00 according to the filing.
- Shares outstanding: The filing lists 50,700,429 shares of common stock outstanding.
- Approximate date of sale: November 10, 2026, to be executed on NASDAQ.
- Source of shares: All securities listed for sale were acquired through restricted stock vesting under a registered plan, with vesting dates ranging from August 11, 2021, to March 22, 2024.
- Prior three-month sales: The filing reports nothing to report for securities sold during the past three months.
Mark Sawicki's Proposed Rule 144 Sale of Cryoport Common Stock
According to the filing, Mark Sawicki, identified as an officer of Cryoport, Inc. (NASDAQ:CYRX), submitted a Form 144 notice proposing to sell 10,000 shares of the company's common stock. The proposed sale is to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The aggregate market value of the shares to be sold is listed as $199,261.00, and the approximate date of sale is stated as November 10, 2026.
The filing details seven separate restricted stock vesting events as the source of the securities proposed for sale. These vesting events occurred under a registered plan, with the issuer listed as the person from whom the shares were acquired in each case. The vesting dates and share amounts are as follows: 2,805 shares on August 11, 2021; 1,257 shares on March 9, 2022; 1,191 shares on March 9, 2023; 1,252 shares on March 14, 2023; 1,000 shares on September 8, 2023; 1,248 shares on March 9, 2024; and 1,247 shares on March 22, 2024. No cash consideration was involved, as the nature of payment is listed as "Not Applicable" for all entries.
The filing also indicates that no securities of Cryoport were sold by Sawicki during the three months preceding the notice. By signing the Form 144, Sawicki represented, as stated in the filing, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." Cryoport, Inc. is headquartered at 112 Westwood Place, Suite 350, Brentwood, Tennessee 37027, and its SEC file number is listed as 001-34632.
What Was Disclosed
Cryoport officer Mark Sawicki filed a Form 144 on November 10, 2026, notifying the SEC of a proposed sale of 10,000 shares of common stock, valued at $199,261.00, all acquired through restricted stock vesting under a registered plan between 2021 and 2024.



Please wait processing your request...